Home GENECAST

GENECAST

In operation
-
Liquid Biopsy Technology Developer
Basic
Enterprise Profile

Basic Information

GENECAST is a biotechnology company specializing in cancer diagnosis using liquid biopsy. Our proprietary technology, ADPS, with a maximum detection sensitivity of 0.0001%, can rapidly and accurately identify tumor mutation genes in traditional liquid biopsy techniques.
GENECAST
Seoul,SeoulSpecialCity,SouthKorea
15~50 people
January 01, 2016
help@igenecast.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design # Diagnostic Manufacturing
Technology
Liquid Biopsy
Concept
Laboratory Diagnosis
Application Scenarios
Medical Device Consumables